Roberta Malaguarnera
Overview
Explore the profile of Roberta Malaguarnera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1775
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salvetat M, Toro M, Pellegrini F, Scollo P, Malaguarnera R, Musa M, et al.
Biomedicines
. 2025 Jan;
12(12.
PMID: 39767592
The management of glaucoma in pregnancy and breastfeeding requires a careful evaluation of treatment choices to guarantee the well-being of both the mother and the developing fetus. This review explores...
2.
Maniaci A, Briglia M, Allia F, Montalbano G, Romano G, Zaouali M, et al.
Biology (Basel)
. 2024 Oct;
13(10).
PMID: 39452111
Inner ear disorders, including sensorineural hearing loss, Meniere's disease, and vestibular neuritis, are prevalent conditions that significantly impact the quality of life. Despite their high incidence, the underlying pathophysiology of...
3.
Briglia M, Allia F, Avola R, Signorini C, Cardile V, Romano G, et al.
Nutrients
. 2024 Sep;
16(18).
PMID: 39339713
: Rare diseases are a wide and heterogeneous group of multisystem life-threatening or chronically debilitating clinical conditions with reduced life expectancy and a relevant mortality rate in childhood. Some of...
4.
De Marco P, Romeo E, Vivacqua A, Malaguarnera R, Abonante S, Romeo F, et al.
Endocr Relat Cancer
. 2023 Oct;
30(12).
PMID: 37855325
No abstract available.
5.
Scamporrino A, Di Mauro S, Filippello A, Di Marco G, Di Pino A, Scicali R, et al.
Int J Mol Sci
. 2023 Jun;
24(11).
PMID: 37298364
Diabetic kidney disease (DKD) is a complication that strongly increases the risk of end-stage kidney disease and cardiovascular events. The identification of novel, highly sensitive, and specific early biomarkers to...
6.
Di Mauro S, Filippello A, Scamporrino A, Purrello F, Piro S, Malaguarnera R
Int J Mol Sci
. 2022 Aug;
23(15).
PMID: 35955455
Metformin, a molecule belonging to the biguanide family, represents one of the most commonly prescribed medications for the treatment of diabetes mellitus in the world. Over the sixty years during...
7.
Malaguarnera R, Gabriele C, Santamaria G, Giuliano M, Vella V, Massimino M, et al.
Mol Cell Endocrinol
. 2022 Aug;
557:111739.
PMID: 35940390
The insulin receptor (IR) gene undergoes differential splicing generating two IR isoforms, IR-A and IR-B. The roles of IR-A in cancer and of IR-B in metabolic regulation are well known...
8.
Di Mauro S, Scamporrino A, Filippello A, Di Marco M, Di Martino M, Scionti F, et al.
Int J Mol Sci
. 2022 Jul;
23(15).
PMID: 35897772
Type 2 diabetes and renal damage are strictly linked. The progressive increase in T2D incidence has stimulated the interest in novel biomarkers to improve the diagnostic performance of the commonly...
9.
Filippello A, Di Mauro S, Scamporrino A, Torrisi S, Leggio G, Di Pino A, et al.
Int J Mol Sci
. 2022 Jul;
23(14).
PMID: 35887100
Intestinal cell dysfunctions involved in obesity and associated diabetes could be correlated with impaired intestinal cell development. To date, the molecular mechanisms underlying these dysfunctions have been poorly investigated because...
10.
Genovese C, Garozzo A, DAngeli F, Malfa G, Bellia F, Tomasello B, et al.
Cells
. 2022 May;
11(10).
PMID: 35626733
Background: Breast cancer (BC) is the leading cause of death worldwide. The severity of BC strictly depends on the molecular subtype. The less aggressive hormone-positive subtype is treated with adjuvant...